Zomedica pharmaceuticals corp. (ZOM)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows used in operating activities:
Net loss

-2,857

-2,845

-2,404

-11,676

-8,421

-1,910

-4,144

-2,171

-2,563

-2,080

-1,588

-1,832

Adjustments for
Depreciation

76

70

68

62

53

86

27

36

23

22

22

20

Amortization - intangible assets

0

0

0

0

0

0

0

0

0

0

0

0

Amortization - right-of-use asset

127

127

127

127

-

-

-

-

-

-

-

-

Loss on fixed asets

-

-

-1

-

-

-

-

-

-

-

-

-

Loss on sale of equipment

-

-

-

-

-

-69

-

-

-

0

-

-

Stock issued for services

0

0

0

792

-

0

1,238

-

230

0

0

45

Stock-based compensation

0

197

0

2,341

0

0

1

5

12

675

0

161

Change in non-cash operating working capital
Trade and other receivable

-8

-19

17

24

15

-11

-19

41

-0

13

-7

4

Prepaid expenses

-99

122

-92

-170

-67

-56

241

6

189

-45

22

37

Deposits

-34

-21

327

-364

520

1,281

60

-30

-56

-34

-1

216

Accounts payable and accrued liabilities

1,669

-1,378

-5,977

5,397

1,096

-403

417

437

445

-128

-533

310

-706

-3,910

-8,436

-2,581

-3,328

-3,371

-2,740

-1,707

-1,984

-1,443

-2,111

-1,553

Cash flows from financing activities:
Cash proceeds from issuance of preferred shares

-

-

12,000

-

-

-

-

-

-

-

-

-

Cash proceeds from issuance of common shares

0

0

0

3,000

-

0

4,002

-

0

3,320

3,000

250

Cash received from stock option exercises

0

0

0

600

497

98

30

1,407

879

60

22

17

Cash paid on stock issuance costs

81

1

33

593

-

12

23

-

3

19

25

8

Repayments of shareholder loan

-

-

-

-

-

0

-

-

0

0

0

-6

-81

-1

11,966

3,006

4,755

86

4,009

1,407

876

3,361

2,997

251

Cash flows used in investing activities:
Investment in intangibles

-

501

-

-

-

-

-

-

-

-

-

-

Investment in property and equipment

-0

80

5

69

22

467

124

13

7

4

2

157

-29

-582

-5

-69

-13

-467

-124

-13

-7

-4

-2

-157

Decrease in cash and cash equivalents

-817

-4,493

3,525

356

1,413

-3,752

1,144

-313

-1,115

1,913

882

-1,459

Supplemental cash flow information:
Interest Paid

-12

12

12

6

-

-

-

-

-

-

-

-